Skip to
  1. Homepage
  2. Rare diseases
  3. Search
Simple search

Simple search

(*) mandatory field


Other search option(s)


Synonym(s) Hyperlysinemia type I
Lysine alpha-ketoglutarate reductase deficiency
Prevalence Unknown
Inheritance Autosomal recessive
Age of onset All ages
  • E72.3
  • C0268553
  • C0936256
  • D020167
MedDRA -


Hyperlysinaemia is a lysine metabolism disorder characterised by elevated levels of lysine in the cerebrospinal fluid and blood. Variable degrees of saccharopinuria are also present. The prevalence is unknown. The disorder was first reported in individuals with neurological problems and intellectual deficit. However, subsequent studies conducted to avoid ascertainment bias identified pronounced hyperlysinaemia in otherwise asymptomatic individuals, suggesting that isolated hyperlysinaemia is not associated with a clinical phenotype. One mother with hyperlysinaemia gave birth to a normal baby. Hyperlysinaemia is transmitted as an autosomal recessive trait. It is caused by a deficiency of the bifunctional enzyme alpha-aminoadipate semialdehyde synthase (AASS gene, 7q31.3). This enzyme has both lysine-ketoglutarate reductase (LKR) and saccharopine dehydrogenase (SDH) activity, and catalyses the first two steps of lysine degradation. In hyperlysinaemia, both enzymatic functions of alpha-aminoadipate semialdehyde synthase are defective. A low lysine diet may be of benefit in some cases.

(*) Required fields.

Attention: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed.

Captcha image
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.